MarkASchattnerMD

Advanced Endoscopic Interventional

Associate Professor, Medicine, Weill Cornell Medical College

Overview of Dr. Schattner

Dr. Mark Schattner is a gastroenterologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 22 years. Dr. Schattner accepts several types of health insurance, listed below. He is one of 35 doctors at Memorial Sloan Kettering Cancer Center who specialize in Gastroenterology. He has more than 100 publications and over 500 citings.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(224) 334-3310

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Gastroenterology, 1999 - 2002
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1998
Perelman School of Medicine at the University of PennsylvaniaClass of 1995

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 1996 - 2026
NJ State Medical License 2017 - 2025
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies Start of enrollment: 2015 Jan 01
Completed
Phase 3
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) Start of enrollment: 2022 Nov 30
Recruiting
Phase 1, Phase 2
Roles: Contact

Publications & Presentations

PubMed

32 citations
Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
Elvira L. Vos, Erin E. Salo-Mullen, Laura H. Tang, Mark A. Schattner, Sam S. Yoon
JAMA Surgery. 2020-11-01
242 citations
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.
Yelena Y. Janjigian, Francisco Sanchez-Vega, Philip Jonsson, Walid K. Chatila, Jaclyn F. Hechtman
Cancer Discovery. 2018-01-01
1 citations
Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication.
Isha Singh, Joanne F Chou, Marinela Capanu, Jennifer Park, Kenneth H Yu
Pancreatology. 2024-06-01

Authored Content

Tu1435 ENDOSCOPIC BILIARY STENTING FOR MALIGNANT BILIARY OBSTRUCTION IS TECHNICALLY SUCCESSFUL IN PATIENTS WITH PRE- EXISTING DUODENAL STENTSMay 2018
Tu1435 ENDOSCOPIC BILIARY STENTING FOR MALIGNANT BILIARY OBSTRUCTION IS TECHNICALLY SUCCESSFUL IN PATIENTS WITH PRE- EXISTING DUODENAL STENTSMay 2018
Predictors of Clinical Outcome of Colonic Stents in Patients with Malignant Large-Bowel Obstruction Due to Extracolonic MalignancyJanuary 2018

Press Mentions

Treatment of Esophageal/Gastroesophageal Junction Adenocarcinoma in Patients with History of Prior Bariatric SurgeryMay 7th, 2023

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment